FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

David Valenta

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Procedures

Anatomy

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
David T Valenta; Joshua J Bulgrien; David J Bonnet; Linda K Curtiss
Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
David T Valenta; Joshua J Bulgrien; Carole L Banka; Linda K Curtiss
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
David T Valenta; Nicolas OGIER; Gary Bradshaw; Audrey S Black; David J Bonnet; Laurent Lagrost; Linda K Curtiss; Catherine Desrumaux
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of David Valenta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2008: David T Valenta; Joshua J Bulgrien; David J Bonnet; Linda K Curtiss
Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
Journal of lipid research 2008;49(1):24-32.
2006: David T Valenta; Joshua J Bulgrien; Carole L Banka; Linda K Curtiss
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
Atherosclerosis 2006;189(2):255-63.
2006: David T Valenta; Nicolas OGIER; Gary Bradshaw; Audrey S Black; David J Bonnet; Laurent Lagrost; Linda K Curtiss; Catherine Desrumaux
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(7):1572-8.
2006: Linda K Curtiss; David T Valenta; Neil J Hime; Kerry-Anne Rye
What is so special about apolipoprotein AI in reverse cholesterol transport?
Arteriosclerosis, thrombosis, and vascular biology 2006;26(1):12-9.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.